Ieq Capital LLC Buys 4,007 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Ieq Capital LLC has increased its stake in HCA Healthcare by 46.0%, holding 12,710 shares valued at approximately $4.39 million.
• HCA Healthcare reported earnings of $6.84 per share for the last quarter, exceeding analyst expectations of $6.20, with significant revenue growth of 6.4% year-over-year.
• The company declared a quarterly dividend of $0.72 per share, scheduled for payment on September 30th, resulting in an annualized yield of 0.7%.

Ieq Capital LLC grew its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 46.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 12,710 shares of the company's stock after purchasing an additional 4,007 shares during the period. Ieq Capital LLC's holdings in HCA Healthcare were worth $4,392,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Samalin Investment Counsel LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter valued at $218,000. Virtus Advisers LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter valued at $110,000. Ally Financial Inc. boosted its holdings in shares of HCA Healthcare by 50.0% during the 1st quarter. Ally Financial Inc. now owns 4,500 shares of the company's stock valued at $1,555,000 after acquiring an additional 1,500 shares in the last quarter. Comerica Bank boosted its holdings in shares of HCA Healthcare by 2.0% during the 1st quarter. Comerica Bank now owns 36,571 shares of the company's stock valued at $12,637,000 after acquiring an additional 715 shares in the last quarter. Finally, ICONIQ Capital LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter valued at $312,000. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Down 0.8%

HCA stock traded down $3.17 during trading on Monday, reaching $404.11. 996,401 shares of the stock were exchanged, compared to its average volume of 1,110,551. The firm's 50 day moving average is $377.43 and its 200 day moving average is $357.80. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The firm has a market cap of $94.56 billion, a P/E ratio of 16.99, a price-to-earnings-growth ratio of 1.27 and a beta of 1.41.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the prior year, the business earned $5.50 EPS. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's payout ratio is currently 12.11%.

Wall Street Analyst Weigh In

Several brokerages have commented on HCA. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $444.00 target price on shares of HCA Healthcare in a report on Tuesday, August 26th. Royal Bank Of Canada cut their target price on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a report on Monday, July 28th. Bank of America downgraded HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 target price on the stock. in a report on Wednesday, July 16th. JPMorgan Chase & Co. lifted their target price on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. Finally, Robert W. Baird boosted their price objective on HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a research note on Thursday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $401.83.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.